GlobeNewswire

PALO ALTO, Calif., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, announced that its first virtual-only Annual Meeting of Stockholders (the “Meeting”) is scheduled to be held on April 6, ...

Primary Logo

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Covenant Logistics Group, Inc. (“Covenant” or the “Company”) (NASDAQ: CVLG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Covenant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sotera Health Co. (“Sotera” or the “Company”) (NASDAQ: SHC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Sotera and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the “Company”) (NASDAQ: YMAB). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Y-mAbs and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of International Business Machines Corporation (“IBM” or the “Company”) (NYSE: IBM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether IBM and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Southwest Airlines Co. (“Southwest” or the “Company”) (NYSE: LUV). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Southwest and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ESS Tech, Inc. (“ESS Tech” or the “Company”) (NYSE: GWH). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether ESS Tech and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BioLineRx Ltd. (“BioLineRx” or the “Company”) (NASDAQ: BLRX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether BioLineRx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gaotu Techedu Inc. f/k/a GSX Techedu (“Gaotu” or the “Company”) (NYSE: GOTU). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Gaotu and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tattooed Chef, Inc. (“Tattooed Chef” or the “Company”) (NASDAQ: TTCF). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Tattooed Chef and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gaia, Inc. (“Gaia” or the “Company”) (NASDAQ: GAIA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Gaia and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Daktronics, Inc. (“Daktronics” or the “Company”) (NASDAQ: DAKT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Daktronics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Atlas Technical Consultants, Inc. (NASDAQ: ATCX) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of ATCX to GI Partners for $12.25 per share in cash. If you are an ATCX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sunlight Financial Holdings Inc. (“Sunlight” or the “Company”) (NYSE: SUNL). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Sunlight and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Twist Bioscience Corporation (“Twist” or the “Company”) (NASDAQ: TWST). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Twist and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Singularity Future Technology Ltd. f/k/a Sino-Global Shipping America Ltd. (“Singularity” or the “Company”) (NASDAQ: SGLY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Singularity and certain of its officers and/or directors have engaged in securities fraud or other unlawful ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of F45 Training Holdings, Inc. (“F45 Training” or the “Company”) (NYSE: FXLV). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether F45 Training and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Veru, Inc. (“Veru” or the “Company”) (NASDAQ: VERU). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Veru and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. (“Fate” or the “Company”) (NASDAQ: FATE). The class action, filed in the United States District Court for the Southern District of California, and docketed under 23-cv-111-WQH-NLS, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fate ...

NEW YORK, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Enovix Corporation (or Rodgers Silicon Valley Acquisition Corp. (“RSVAC”) (“Enovix” or the “Company”) (NASDAQ: ENVX; RSVAC). The class action, filed in the United States District Court for the Northern District of California, and docketed under 23-cv-00372, is on behalf of a class consisting of all persons and entities other than ...